FDA approves Progenics ' drug for rare tumors

The drug, Azedra, was approved to treat patients above the age of 12 who have either of the two tumors, pheochromocytoma or paraganglioma, and require anti-cancer therapy
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news